| Net Cash Provided by (Used in) Operating Activities |
$57,789 |
USD |
-36% |
Q3 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$62,000 |
USD |
|
Q3 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
111,238,932 |
shares |
5.5% |
Q3 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$4,211 |
USD |
|
Q3 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,275 |
USD |
0% |
Q3 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$207,800 |
USD |
35% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$207,800 |
USD |
35% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q1 2025 |
| Additional Paid in Capital |
$3,587,208 |
USD |
11% |
Q3 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$13,175 |
USD |
15% |
Q3 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2025 |